The Oxford Risk Factors And Non-Invasive Imaging Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorUniversity of Oxford
About this trial
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
Eligibility criteria
Qualifiers
Participant is willing and able to give informed consent for participation in the study.
Male or Female, aged 18 -99 years.
Disqualifiers
Unable or unwilling to consent
Active cancer
Participation in Study Arms 1, 2 or 3
Existing opt-out from use of data for research purposes
Trial design
Treatments tested in this trial
- Not listed
Trial groups
250,000 Participants
are grouped into 4 trial groupsLocations
37Australia
Flinders University Adelaide Australia
The University of Sydney Sydney Australia
Belgium
University Hospitals Leuven Leuven Belgium
China
Fudan University Shanghai China
Sponsors and collaborators
University of Oxford
Lead sponsor
Caristo Diagnostics Limited
Collaborator
Oxford University Hospitals NHS Trust
Collaborator
British Heart Foundation
Collaborator
Innovate UK
Collaborator
European Commission
Collaborator
National Consortium of Intelligent Medical Imaging
Collaborator
Source ClinicalTrials.gov